Genialis and Debiopharm Set Up Biomarker Discovery Collaboration

Contributed by: Business Wire

Logo

Tags

Oncology

Health

Technology

Artificial Intelligence

Pharmaceutical

Biotechnology

Genialis

More Like This

Genialis and Cancer Research Horizons Collaborate to Develop AI-Driven Patient Classifiers

Debiopharm & WhiteLab Genomics Announce a Strategic Partnership to Advance Drug Target and Design in Oncology

Debiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate Family

Debiopharm to Showcase Research Results of Their DDR Inhibitors at the 2024 AACR Conference in San Diego

Denovo Biopharma Announces a Major Breakthrough in Treatment‑Resistant Depression with Precision Medicine

TNL’s AI Digital Cells Lab platform and Debiopharm’s deep pharmaceutical expertise may bring cancer drugs into new frontiers of innovation (Graphic: Business Wire)

Debiopharm and ThinkingNodeLife.ai Forge a Strategic Partnership to Propel Cancer Drug Development with AI Digital Cell Clones

Debiopharm Recognizes Groundbreaking Japanese Cancer Research During the 83rd Annual Meeting of the Japanese Cancer Association

Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery